Fatty liver disease happens when a person’s body begins to store fat in the liver, which can damage the organ. Some forms of fatty liver disease are caused by excessive alcohol use.

The FDA has approved a new targeted drug specifically for brain tumors called low-grade gliomas. The drug, vorasidenib, was shown in clinical trials to delay progression of low-grade gliomas that had mutations in the IDH1 or IDH2 genes.

Mary E. Klotman, MD, welcomes all new medical students and chats with Trevor Sytsma and Niki Young about why they chose Duke, and what advice they have for incoming students.

The symposium showcases the unique curriculum at Duke University School of Medicine, where students gain invaluable research experience while pursuing their medical degrees.

Mapping the structure of an enzyme crucial for fungal survival also sheds light on how climate change is affecting the fungal world.

Through internship with a Durham health clinic, students learn the challenges immigrants face in navigating the U.S. health system – and help patients solve them

New research reveals shape-shifting proteins may help some organisms, like plants, adapt to rising temperatures. But this same ability could also lead to the emergence of dangerous fungal pathogens

Researchers at Duke Health and St. Jude’s Research Hospital launched a study of ALS recovery patients and found certain genetic factors that appear to protect against the disease’s typical assault on motor neurons.

Elle Hepburn Reason, a third-year MD student, and James White, a first-year MD student, were named to this year’s class of Tillman Scholars.

During a recent visit to the Duke-NUS Medical School, Dean Klotman had the opportunity to sit down for a conversation with esteemed cancer researcher Dr. David Virshup to discuss his time in Singapore and why the collaboration is important.